Загрузка...
A breast cancer gene signature for indolent disease
PURPOSE: Early-stage hormone-receptor positive breast cancer is treated with endocrine therapy and the recommended duration of these treatments has increased over time. While endocrine therapy is considered less of a burden to patients compared to chemotherapy, long-term adherence may be low due to...
Сохранить в:
| Опубликовано в: : | Breast Cancer Res Treat |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5487706/ https://ncbi.nlm.nih.gov/pubmed/28451965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4262-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|